CBDX OTC
Curative Biosciences, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -90.0%
5Y: -92.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$3K
+0.0% ▲
Operating Income
-$53K
+96.8% ▲
Net Income
-$53K
+96.8% ▲
EPS (Diluted)
$-0.00
+97.2% ▲
EBITDA
-$50K
+97.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2016 | FY2017 |
|---|---|---|
| Revenue | $0 | $0 |
| YoY Growth | +0.0% | +0.0% |
| Cost of Revenue | $3K | $3K |
| Gross Profit | -$3K | -$3K |
| Gross Margin | — | — |
| R&D Expenses | $50K | $0 |
| SG&A Expenses | $2M | $50K |
| Operating Expenses | $2M | $50K |
| Operating Income | -$2M | -$53K |
| Operating Margin | — | — |
| Interest Expense | $0 | $0 |
| Income Before Tax | -$2M | -$53K |
| Tax Expense | $3 | $2 |
| Net Income | -$2M | -$53K |
| Net Margin | — | — |
| EPS (Diluted) | $-0.12 | $-0.00 |
| EBITDA | -$2M | -$50K |
| Shares Outstanding | 14M | 16M |